Clarification of Optimal Anticoagulation through Genetics (COAG)
ID Number 08-0838Principal Investigator(s)
Robert J. Desnick
Department(s) or Division(s)
Genetics and Genomic Sciences
The purpose of this study is to find out the best way to start warfarin treatment. This study will test whether doctors can improve the control of blood thinning by using genetic information. This information is thought to improve the safe use of warfarin since choosing the correct warfarin dose is important to prevent blood clots and avoid bleeding.
Dana O. Doheny, MS, CGC
Recruiting Patients: Yes